PEDIATRICS Vol. 62 No. 6 December 1978, pp. 1189-1195
This Article
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Crawford, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crawford, J. D.

Treatment of Tall Girls With Estrogen

John D. Crawford M.D.1

1 Children's Service, Massachusetts General Hospital, Boston

The practice of giving estrogen to normal girls destined to become taller than they wish goes back to the 1940s. The train of thought leading up to the first trials includes two basic observations. First, it was noted that children in whom persistent precocity syndromes develop early in life become short adults and have premature epiphyseal closure. Second, and conversely, in the absence of the gonadal steroids, the epiphyses remain open indefinitely and growth continues beyond the usual age of cessation. While the majority of these cases are complicated by the presence of pituitary disease and the fact that because of their lack of growth hormone the patients are small, the early clinicians bolstered their faith in the converse by their admiration of the enormous size reputed to be attained by the harem eunuchs.

These observations prompted two conclusions. First, gonadal steroids were not only responsible for closing the epiphyses but also for "turning off" secretion of growth hormone. Thus, in the early 1930s, it was reasoned that while children would be well endowed, adults must lack any circulating pituitary growth hormone, save in the rare instance of acromegaly. These were the concepts that led to the treatment of that disorder first with gonadal extracts,1,2 then, when pure steroids became available, with androgens and estrogens.3 The effect of testosterone was disappointing; the beneficial influence of estrogen, however, was so impressive as to be taken as proof of the earlier drawn conclusion that it is the gonadal steroids that normally turn off growth hormone secretion at adolescence.




This article has been cited by other articles:


Home page
 J. Med. EthicsHome page
P Louhiala
How tall is too tall? On the ethics of oestrogen treatment for tall girls
J. Med. Ethics, January 1, 2007; 33(1): 48 - 50.
[Abstract] [Full Text] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
J. M. Lee and J. D. Howell
Tall girls: the social shaping of a medical therapy.
Arch Pediatr Adolesc Med, October 1, 2006; 160(10): 1035 - 1039.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
G. Maor, Y. Segev, and M. Phillip
Testosterone Stimulates Insulin-Like Growth Factor-I and Insulin-Like Growth Factor-I-Receptor Gene Expression in the Mandibular Condyle--A Model of Endochondral Ossification
Endocrinology, April 1, 1999; 140(4): 1901 - 1910.
[Abstract] [Full Text]

Home page
 Endocr. Rev.Home page
S. L. S. Drop, W. J. de Waal, and S. M. P. F. de Muinck Keizer-Schrama
Sex Steroid Treatment of Constitutionally Tall Stature
Endocr. Rev., October 1, 1998; 19(5): 540 - 558.
[Abstract] [Full Text]

Home page
 PediatricsHome page
R. L. Rosenfield, N. Perovic, N. Devine, N. Mauras, T. Moshang, A. W. Root, and J. P. Sy
Optimizing Estrogen Replacement Treatment in Turner Syndrome
Pediatrics, August 1, 1998; 102(2): 486 - 488.
[Abstract] [Full Text]

Home page
 Arch. Dis. Child.Home page
E Weimann, S Bergmann, and H J Böhles
Oestrogen treatment of constitutional tall stature: a risk-benefit ratio
Arch. Dis. Child., February 1, 1998; 78(2): 148 - 151.
[Abstract] [Full Text]

Home page
 CLIN PEDIATRHome page
J. F. Sotos
Overgrowth
Clinical Pediatrics, October 1, 1996; 35(10): 515 - 529.
[PDF]